Searched for
OPHTHALMOLOGY INNOVATION
In 1988, Patricia Bath patented a device that used a laser through a tiny 1 mm incision to remove a cataract, turning the procedure into a matter of minutesDr. Patricia Bath made a groundbreaking advancement in cataract surgery with her invention of the Laserphaco Probe, utilizing cutting-edge ...- ENTOD Pharmaceuticals secures patent for its insulin eye dropCurrently at the pre-clinical stage of development, the patented insulin eye drops are being investigated as a potential novel therapeutic ...
- ET Startup Awards 2026: Theranautilus’ nanorobots will be ready for human trials by year-endTheranautilus won the Top Innovator category at The Economic Times Startup Awards 2026 for its unique nanorobot technology, which is built ...
- ET Startup Awards 2026 | Top Innovator: Deeptech startup Theranautilus’ micro robots score big winDeeptech startup Theranautilus has won the Top Innovator award at the ET Startup Awards 2026 for its work on microscopic robots that can na...
- Lupin arm to commercialise YUVEZZI eye drop across key European marketsLupin's VISUfarma BV has secured exclusive rights for YUVEZZI in key European markets. This ophthalmic product treats loss of clear close-u...
- ET Health Conclave 2026: Healthcare leaders reimagine the future of medicine through innovation, prevention and technologyThe ET Health Conclave 2026 celebrated healthcare professionals and institutions. Leaders shared insights on healthcare infrastructure and ...
- Screens are straining young eyes, and Alcon sees India's opportunityAlcon is increasing investments in India, recognizing its significant emerging market potential. The company focuses on innovation and surg...
- Biocon not to rush generic semaglutide to packed India market, says incoming CEO Shreehas TambeBiocon will delay its Indian launch of semaglutide. The company is focusing on international markets for the diabetes and weight-management...
- Lupin subsidiary inks pact to acquire Netherlands-based VISUfarmaLupin's subsidiary will acquire VISUfarma BV for 190 million euros. This expands Lupin's European business and eye health product range. Th...
- 'Discover and Make in India' to drive innovation in pharma, says Dilip Shanghvi, Founder & Managing Director, Sun Pharmaceutical IndustriesIndia has established itself as a global leader in pharmaceutical production, with potential for further growth through increased investmen...
- Project SPECS of WHO will soon be implemented in AssamThe World Health Organization (WHO) is partnering with Sri Sankaradeva Nethralaya (SSDN) to launch the SPECS project in Assam, India. This ...
- Bayer acquires remaining 25% stake in Bayer Zydus Pharma Pvt Ltd to secure full ownershipBayer Pharmaceuticals Private Limited and Zydus Lifesciences Limited have concluded their joint venture, Bayer Zydus Pharma Private Limited...
- JB Pharma acquires trademark licenses, distribution rights of Novartis eye care portfolio in India for Rs 1089 croreJB will pay Rs 964 crore for the portfolio licensing agreement with Novartis Innovative Therapies AG which the company said is "perpetual i...
- JB Pharma inks Rs 1,089 cr pacts with Novartis for select ophthalmology brandsThe board of directors at its meeting held on December 19, 2023 approved the execution of a trade mark licence agreement with Novartis Inno...
- Viatris buys Taparias' eyecare business for Rs 2,460 croreThe ophthalmology portfolio consists of six new chemical entities (NCEs or molecules) that are under phase 3 trials and will be developed f...
- Sun Pharma, other drug cos say innovative products to contribute substantially in futureSun Pharma, India's largest drug maker, said it expects its innovative products to garner $1.5 billion in sales in the next 3-4 years.
- Cadila, Bayer extend JV partnership for three years"The spirit of partnership in this joint venture has all been about channelling the core strengths of both Zydus and Bayer for the benefit ...
- Indian drug regulator backs off over use of Roche’s AvastinThe Drug Controller General of India has passed an order removing an alert notice for the use of Roche’s Avastin (bevacizumab) injection to...
- Stelis Biopharma, Pieris AG join hand for drug developmentStelis Biopharma, a subsidiary of Bangalore-based Strides Arcolab Ltd, said it has entered into a long-term agreement with Germany's Pieris...
- Lupin expects to launch 20 products in US next fiscalDrug major Lupin expects to strengthen its US pipeline by launching around 20 products in the next fiscal (2014-15).
Load More
